HOME
Donate now
EN FR
EN FR

Evidence Synthesis and Classification Branch (ESC)

Publications

All recent publications: 2024-2020

View Key Publications

 

  1. Colling R, Indave I, Del Aguila J, Jimenez RC, Campbell F, Chechlińska M, et al. (2024). A New Hierarchy of Research Evidence for Tumor Pathology: A Delphi Study to Define Levels of Evidence in Tumor Pathology. Mod Pathol. 37(1):100357. https://doi.org/10.1016/j.modpat.2023.100357 PMID:37866639
  2. Harewood R, Rothwell JA, Bešević J, Viallon V, Achaintre D, Gicquiau A, et al. (2024). Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). EBioMedicine. 101:105024. https://doi.org/10.1016/j.ebiom.2024.105024 PMID:38412638
  3. Kreuzer M, Sommer M, Deffner V, Bertke S, Demers PA, Kelly-Reif K, et al. (2024). Lifetime excess absolute risk for lung cancer due to exposure to radon: results of the pooled uranium miners cohort study PUMA. Radiat Environ Biophys. 63(1):7–16. https://doi.org/10.1007/s00411-023-01049-w PMID:38172372
  4. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. (2024). The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 4(3):100500. https://doi.org/10.1016/j.xgen.2024.100500 PMID:38325367
  5. Senkin S, Moody S, Díaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013):910–8. https://doi.org/10.1038/s41586-024-07368-2 PMID:38693263
  6. Shafique A, Gonzalez R, Pantanowitz L, Tan PH, Machado A, Cree IA, et al. (2024). A Preliminary Investigation into Search and Matching for Tumor Discrimination in World Health Organization Breast Taxonomy Using Deep Networks. Mod Pathol. 37(2):100381. https://doi.org/10.1016/j.modpat.2023.100381 PMID:37939901
  7. Tran TV, Schonfeld SJ, Pasqual E, Haymart MR, Morton LM, Kitahara CM (2024). All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States. Thyroid. 34(2):215–24. https://doi.org/10.1089/thy.2023.0449 PMID:38149602
  8. Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol. 25(1):16–7. https://doi.org/10.1016/S1470-2045(23)00622-8 PMID:38043561
  9. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E, et al.; International Agency for Research on Cancer/World Health Organization (2023). Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 37(9):1944–51. https://doi.org/10.1038/s41375-023-01962-5 PMID:37468552
  10. Bresalier RS, Senore C, Young GP, Allison J, Benamouzig R, Benton S, et al.; Members of the World Endoscopy Colorectal Cancer Screening New Test Evaluation Expert Working Group (2023). An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. 72(10):1904–18. https://doi.org/10.1136/gutjnl-2023-329701 PMID:37463757
  11. Canberk S, Field A, Bubendorf L, Chandra A, Cree IA, Engels M, et al. (2023). A brief review of the WHO reporting system for lung cytopathology. J Am Soc Cytopathol. 12(4):251–7. https://doi.org/10.1016/j.jasc.2023.04.002 PMID:37156705
  12. Cattley RC, Kromhout H, Sun M, Tokar EJ, Abdallah MA, Bauer AK, et al. (2023). Carcinogenicity of anthracene, 2-bromopropane, butyl methacrylate, and dimethyl hydrogen phosphite. Lancet Oncol. 24(5):431–2. https://doi.org/10.1016/S1470-2045(23)00141-9 PMID:36966774
  13. Cree IA (2023). Editorial: The new WHO cytopathology reporting systems-extending the WHO classification of tumors. J Am Soc Cytopathol. 12(4):239–42. https://doi.org/10.1016/j.jasc.2023.04.004 PMID:37244847
  14. Cree IA, Khoury JD (2023). WHO or International Consensus Classification: Is the Difference Worth It? J Clin Oncol. 41(31):4937–8. https://doi.org/10.1200/JCO.23.01172 PMID:37467455
  15. DeBono NL, Daniels RD, Beane Freeman LE, Graber JM, Hansen J, Teras LR, et al. (2023). Firefighting and Cancer: A Meta-analysis of Cohort Studies in the Context of Cancer Hazard Identification. Saf Health Work. 14(2):141–52. https://doi.org/10.1016/j.shaw.2023.02.003 PMID:37389311
  16. Gapstur SM, Bouvard V, Nethan ST, Freudenheim JL, Abnet CC, English DR, et al. (2023). The IARC Perspective on Alcohol Reduction or Cessation and Cancer Risk. N Engl J Med. 389(26):2486–94. https://doi.org/10.1056/NEJMsr2306723 PMID:38157507
  17. Gregório C, Thakur S, Camara Rivero R, Márcia Dos Santos Machado S, Cuenin C, Carreira C, et al. (2023). Telomere length assessment and molecular characterization of TERT gene promoter in periampullary carcinomas. Gene. 873:147460. https://doi.org/10.1016/j.gene.2023.147460 PMID:37150235
  18. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Burgess S, Khankari NK, et al.; ACCC; CCFR-CORECT-GECCO; EPITHYR; InterLymph; MMAC; ECAC; ILCCO; PRACTICAL Consortium; PanScan; PanC4; Fatty Acids in Cancer Mendelian Randomization Collaboration (2023). The association between genetically elevated polyunsaturated fatty acids and risk of cancer. EBioMedicine. 91:104510. https://doi.org/10.1016/j.ebiom.2023.104510 PMID:37086649
  19. Kelly-Reif K, Bertke S, Daniels RD, Richardson DB, Schubauer-Berigan MKD (2023). Authors’ response: Solid cancer mortality among US radiation workers. Int J Epidemiol. 52(6):1994–5. https://doi.org/10.1093/ije/dyad132 PMID:37741933
  20. Kelly-Reif K, Bertke SJ, Daniels RD, Richardson DB, Schubauer-Berigan MK (2023). Ionizing radiation and solid cancer mortality among US nuclear facility workers. Int J Epidemiol. 52(4):1015–24. https://doi.org/10.1093/ije/dyad075 PMID:37253388
  21. Kelly-Reif K, Bertke SJ, Rage E, Demers PA, Fenske N, Deffner V, et al. (2023). Radon and lung cancer in the pooled uranium miners analysis (PUMA): highly exposed early miners and all miners. Occup Environ Med. 80(7):385–91. https://doi.org/10.1136/oemed-2022-108532 PMID:37164624
  22. Lennerz JK, Salgado R, Kim GE, Sirintrapun SJ, Thierauf JC, Singh A, et al. (2023). Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML. Clin Chem Lab Med. 61(4):544–57. https://doi.org/10.1515/cclm-2022-1151 PMID:36696602
  23. M Filho A, Turner MC, Warnakulasuriya S, Richardson DB, Hosseini B, Kamangar F, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. Eur J Epidemiol. 38(4):373–89. https://doi.org/10.1007/s10654-023-00969-7 PMID:36773182
  24. Malir F, Pickova D, Toman J, Grosse Y, Ostry V (2023). Hazard characterisation for significant mycotoxins in food. Mycotoxin Res. 39(2):81–93. https://doi.org/10.1007/s12550-023-00478-2 PMID:36930431
  25. Mandrik O, Roitberg F, Lauby-Secretan B, Parak U, Ramadas K, Varenne B, et al. (2023). Perspective on oral cancer screening: Time for implementation research and beyond. J Cancer Policy. 35:100381. https://doi.org/10.1016/j.jcpo.2022.100381 PMID:36599217
  26. Md Nasir ND, Koh VCY, Cree IA, Ruiz BII, Del Aguila J, Armon S, et al. (2023). Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. Histopathology. 82(5): 704-712.
  27. Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, et al. (2023). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4):508–20. https://doi.org/10.1111/his.14824 PMID:36221864
  28. Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, et al. (2023). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4):508–20. https://doi.org/10.1111/his.14824 PMID:36221864
  29. Milman T, Grossniklaus HE, Goldman-Levy G, Kivelä TT, Coupland SE, White VA, et al.; WHO Classification of Tumours Editorial Board (2023). The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit. Ocul Oncol Pathol. 9(3-4):71–95. https://doi.org/10.1159/000530730 PMID:37900189
  30. Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, et al. (2023). Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. 83(4):301–3. https://doi.org/10.1016/j.eururo.2022.09.015 PMID:36202687
  31. Pedroso CM, Normando AGC, Siracusa CS, Lauby-Secretan B, Nethan ST, Tomasi RA, et al. (2023). Pan-American prevalence of smokeless tobacco use and association with oral potentially malignant disorders and head and neck cancer: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 136(3):322–32. https://doi.org/10.1016/j.oooo.2023.02.019 PMID:37076380
  32. Pega F, Momen NC, Streicher KN, Leon-Roux M, Neupane S, Schubauer-Berigan MK, et al.; Technical Advisory Group on Occupational Burden of Disease Estimation (2023). Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000-2019: A systematic analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 181:108226. https://doi.org/10.1016/j.envint.2023.108226 PMID:37945424
  33. Pitman MB, Centeno BA, Reid MD, Saeig M, Siddiqui MT, Layfield LJ, et al. (2023). A brief review of the WHO reporting system for pancreaticobiliary cytopathology. J Am Soc Cytopathol. 12(4):243–50. https://doi.org/10.1016/j.jasc.2023.03.002 PMID:37003924
  34. Pitman MB, Centeno BA, Reid MD, Siddiqui MT, Layfield LJ, Perez-Machado M, et al. (2023). The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Acta Cytol. 67(3):304–20. https://doi.org/10.1159/000527912 PMID:36516741
  35. Riboli E, Beland FA, Lachenmeier DW, Marques MM, Phillips DH, Schernhammer E, et al. (2023). Carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lancet Oncol. 24(8):848–50. https://doi.org/10.1016/S1470-2045(23)00341-8 PMID:37454664
  36. Richardson DB, Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, et al. (2023). Cancer mortality after low dose exposure to ionising radiation in workers in France, the United Kingdom, and the United States (INWORKS): cohort study. BMJ. 382:e074520. https://doi.org/10.1136/bmj-2022-074520 PMID:37586731
  37. Rubin MA, Amin MB, Compérat E, Gill A, Hartman A, Menon S, et al. (2023). Reply to Yongbao Wei, Haijian Huang, and Liefu Ye’s Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82. Eur Urol. 83(1):e16–7. https://doi.org/10.1016/j.eururo.2022.09.021 PMID:36202688
  38. Schmitt FC, Bubendorf L, Canberk S, Chandra A, Cree IA, Engels M, et al. (2023). The World Health Organization Reporting System for Lung Cytopathology. Acta Cytol. 67(1):80–91. https://doi.org/10.1159/000527580 PMID:36509066
  39. Schorb S, Gleiss K, Wedekind R, Suonio E, Kull AK, Kuntz M, et al. (2023). Assessment of Aspartame (E951) Occurrence in Selected Foods and Beverages on the German Market 2000-2022. Foods. 12(11):2156. https://doi.org/10.3390/foods12112156 PMID:37297402
  40. Schubauer-Berigan MK (2023). Invited Perspective: Good Measure-Assessing the Impact of Cancer Hazard Identification on Policies for Cancer Prevention. Environ Health Perspect. 131(12):121302. https://doi.org/10.1289/EHP14099 PMID:38088578
  41. Schubauer-Berigan MK, Richardson DB, Fox MP, Fritschi L, Guseva Canu I, Pearce N, et al. (2023). IARC-NCI workshop on an epidemiological toolkit to assess biases in human cancer studies for hazard identification: beyond the algorithm. Occup Environ Med. 80(3):119–20. https://doi.org/10.1136/oemed-2022-108724 PMID:36717257
  42. Siebert R, Schuh A, Ott G, Cree IA, Du MQ, Ferry J, et al. (2023). Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors. Leukemia. 37(5):1170–2. https://doi.org/10.1038/s41375-023-01872-6 PMID:36973349
  43. Simms KT, Keane A, Nguyen DTN, Caruana M, Hall MT, Lui G, et al. (2023). Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nat Med. 29(12):3050–8. https://doi.org/10.1038/s41591-023-02600-4 PMID:38087115
  44. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2):e197–206. https://doi.org/10.1016/S2214-109X(22)00501-0 PMID:36528031
  45. Turner MC, Cogliano V, Guyton K, Madia F, Straif K, Ward EM, et al. (2023). Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned. Environ Health Perspect. 131(10):105001. https://doi.org/10.1289/EHP12547 PMID:37902675
  46. Van Puyvelde H, Dimou N, Katsikari A, Indave Ruiz BI, Godderis L, Huybrechts I, et al. (2023). The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis. Cancer Epidemiol. 83:102322. https://doi.org/10.1016/j.canep.2023.102322 PMID:36701983
  47. Zablotska LB, Richardson DB, Golden A, Pasqual E, Smith B, Rage E, et al. (2023). The epidemiology of lung cancer following radiation exposure. Int J Radiat Biol. 99(3):569–80. https://doi.org/10.1080/09553002.2022.2110321 PMID:35947399
  48. Baan, R. A., & Straif, K. (2022). The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble. ALTEX. 39(3): 443-450. PMID: 34164695 https://doi.org/10.14573/altex.2004081         
  49. Beard, J. D., Verdeja, M. A., Bonsrah, D. A., Westfall, S. D., Steege, A. L., & Schubauer-Berigan, M. K. (2022). Crosswalks to Convert US Census Bureau Industry and Occupation Codes, 1980-2018. Epidemiology. 33(2): e8-e9. PMID: 34799471 https://doi.org/10.1097/EDE.0000000000001440            
  50. Berney, D. M., Cree, I., Rao, V., Moch, H., Srigley, J. R., Tsuzuki, T., . . . Tickoo, S. K. (2022). An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology. 81(4): 459-466. PMID: 35502823 https://doi.org/10.1111/his.14675               
  51. Bouvard, V., Nethan, S. T., Singh, D., Warnakulasuriya, S., Mehrotra, R., Chaturvedi, A. K., . . . Lauby-Secretan, B. (2022). IARC Perspective on Oral Cancer Prevention. New England Journal of Medicine. 387(21): 1999-2005. PMID: 36378601 https://doi.org/10.1056/NEJMsr2210097             
  52. Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., . . . Lauby-Secretan, B. (2022). The IARC Perspective on Cervical Cancer Screening. Obstetrical and Gynecological Survey. 77(3): 154-156. PMID: https://doi.org/10.1097/Ogx.0000000000001017            
  53. Cierco Jimenez, R., Lee, T., Rosillo, N., Cordova, R., Cree, I. A., Gonzalez, A., & Indave Ruiz, B. I. (2022). Machine learning computational tools to assist the performance of systematic reviews: A mapping review. BMC Medical Research Methodology. 22(1): 322. PMID: 36522637 https://doi.org/10.1186/s12874-022-01805-4        
  54. Comperat, E., Amin, M. B., Berney, D. M., Cree, I., Menon, S., Moch, H., . . . Tsuzuki, T. (2022). What’s new in WHO fifth edition – urinary tract. Histopathology. 81(4): 439-446. PMID: 35942645 https://doi.org/10.1111/his.14764             
  55. Cree, I. A. (2022). The WHO classification of haematolymphoid tumours: response to Swerdlow et al. Leukemia. 36(11): 2750. PMID: 36171281 https://doi.org/10.1038/s41375-022-01694-y    
  56. Cree, I. A. (2022). The WHO Classification of Haematolymphoid Tumours. Leukemia. 36(7): 1701-1702. PMID: 35732830 https://doi.org/10.1038/s41375-022-01625-x          
  57. Cree, I. A. (2022). From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors. Endocrine Pathology. 33(1): 3-5. PMID: 35028827 https://doi.org/10.1007/s12022-021-09701-1            
  58. Del Aguila Mejia, J., Armon, S., Campbell, F., Colling, R., Chechlinska, M., Kowalewska, M., . . . Indave Ruiz, B. I. (2022). Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung. BMJ Open. 12(10): e061240. PMID: 36220326 https://doi.org/10.1136/bmjopen-2022-061240               
  59. Demers, P. A., DeMarini, D. M., Fent, K. W., Glass, D. C., Hansen, J., Adetona, O., . . . Schubauer-Berigan, M. K. (2022). Carcinogenicity of occupational exposure as a firefighter. Lancet Oncology. 23(8): 985-986. PMID: 35780778 https://doi.org/10.1016/S1470-2045(22)00390-4             
  60. Goodman, S., Chappell, G., Guyton, K. Z., Pogribny, I. P., & Rusyn, I. (2022). Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review. Mutat Res Rev Mutat Res. 789: 108408. PMID: 35690411 https://doi.org/10.1016/j.mrrev.2021.108408      
  61. Guseva Canu, I., Gaillen-Guedy, A., Antilla, A., Charles, S., Fraize-Frontier, S., Luce, D., . . . Richardson, D. B. (2022). Lung cancer mortality in the European cohort of titanium dioxide workers: a reanalysis of the exposure-response relationship. Occupational and Environmental Medicine. 79(9): 637-640. PMID: 35501125 https://doi.org/10.1136/oemed-2021-108030    
  62. Indave, B. I., Colling, R., Campbell, F., Tan, P. H., & Cree, I. A. (2022). Evidence-levels in pathology for informing the WHO classification of tumours. Histopathology. 81(4): 420-425. PMID: 36089568 https://doi.org/10.1111/his.14648     
  63. Indave Ruiz, B. I., Armon, S., Watanabe, R., Uttley, L., White, V. A., Lazar, A. J., & Cree, I. A. (2022). Clonality, Mutation and Kaposi Sarcoma: A Systematic Review. Cancers. 14(5): 14. PMID: 35267506 https://doi.org/10.3390/cancers14051201    
  64. Karagas, M. R., Wang, A., Dorman, D. C., Hall, A. L., Pi, J., Sergi, C. M., . . . Schubauer-Berigan, M. K. (2022). Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy. Lancet Oncology. 23(5): 577-578. PMID: 35397803 https://doi.org/10.1016/S1470-2045(22)00219-4             
  65. Kelly-Reif, K., Bertke, S., Daniels, R. D., Richardson, D. B., & Schubauer-Berigan, M. K. (2022). Nonmalignant respiratory disease mortality in male Colorado Plateau uranium miners, 1960-2016. American Journal of Industrial Medicine. 65(10): 773-782. PMID: 35941829 https://doi.org/10.1002/ajim.23419  
  66. Kelly-Reif, K., Bertke, S. J., Samet, J., Sood, A., & Schubauer-Berigan, M. K. (2022). Health burdens of uranium miners will extend beyond the radiation exposure compensation act deadline. Occupational and Environmental Medicine. 79(7): 503-504. PMID: 35501126 https://doi.org/10.1136/oemed-2022-108311              
  67. Kelly-Reif, K., Sandler, D. P., Shore, D., Schubauer-Berigan, M., Troester, M., Nylander-French, L., & Richardson, D. B. (2022). Lung and extrathoracic cancer incidence among underground uranium miners exposed to radon progeny in the Pribram region of the Czech Republic: a case-cohort study. Occupational and Environmental Medicine. 79(2): 102-108. PMID: 34417337 https://doi.org/10.1136/oemed-2021-107392               
  68. Kench, J. G., Amin, M. B., Berney, D. M., Comperat, E. M., Cree, I. A., Gill, A. J., . . . Srigley, J. R. (2022). WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. Histopathology. 81(4): 447-458. PMID: 35758185 https://doi.org/10.1111/his.14711        
  69. Lauby-Secretan, B., Mackie, A., & Wentzensen, N. (2022). The IARC Perspective on Cervical Cancer Screening. Reply. New England Journal of Medicine. 386(6): 607-608. PMID: 35139285 https://doi.org/10.1056/NEJMc2119177         
  70. Lobo, J., Ohashi, R., Amin, M. B., Berney, D. M., Comperat, E. M., Cree, I. A., . . . Moch, H. (2022). WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology. 81(4): 426-438. PMID: 35596618 https://doi.org/10.1111/his.14700               
  71. Luchini, C., Pantanowitz, L., Adsay, V., Asa, S. L., Antonini, P., Girolami, I., . . . Scarpa, A. (2022). Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring. Modern Pathology. 35(6): 712-720. PMID: 35249100 https://doi.org/10.1038/s41379-022-01055-1  
  72. Martins, B., Normando, A. G. C., Rodrigues-Fernandes, C. I., Wagner, V. P., Kowalski, L. P., Marques, S. S., . . . Santos-Silva, A. R. N. (2022). Global frequency and epidemiological profile of electronic cigarette users: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 548-561. PMID: 36182650 https://doi.org/10.1016/j.oooo.2022.07.019      
  73. Menon, S., Moch, H., Berney, D. M., Cree, I. A., Srigley, J. R., Tsuzuki, T., . . . Amin, M. B. (2022). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4): 508-520. PMID: 36221864 https://doi.org/10.1111/his.14824          
  74. Michels, N., Zouiouich, S., Vanderbauwhede, B., Vanacker, J., Indave Ruiz, B. I., & Huybrechts, I. (2022). Human microbiome and metabolic health: An overview of systematic reviews. Obesity Reviews. 23(4): e13409. PMID: 34978141 https://doi.org/10.1111/obr.13409         
  75. Middleton, D. R. S., Mmbaga, B. T., Menya, D., Dzamalala, C., Nyakunga-Maro, G., Finch, P., . . . Esccape (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. PMID: 34921758 https://doi.org/10.1016/S2214-109X(21)00506-4        
  76. Moch, H., Amin, M. B., Berney, D. M., Comperat, E. M., Gill, A. J., Hartmann, A., . . . Netto, G. J. N. (2022). The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. European Urology. 82(5): 458-468. PMID: 35853783 https://doi.org/10.1016/j.eururo.2022.06.016   
  77. Netto, G. J., Amin, M. B., Berney, D. M., Comperat, E. M., Gill, A. J., Hartmann, A., . . . Moch, H. (2022). The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. European Urology. 82(5): 469-482. PMID: 35965208 https://doi.org/10.1016/j.eururo.2022.07.002   
  78. Paglioni, M. P., Khurram, S. A., Ruiz, B. I. I., Lauby-Secretan, B., Normando, A. G., Ribeiro, A. C. P., . . . Santos-Silva, A. R. (2022). Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 573-587. PMID: 36153299 https://doi.org/10.1016/j.oooo.2022.07.006  
  79. Paglioni, M. P., Khurram, S. A., Ruiz, B. I. I., Lauby-Secretan, B., Normando, A. G., Ribeiro, A. C. P., . . . Santos-Silva, A. R. N. (2022). Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 573-587. PMID: 36153299 https://doi.org/10.1016/j.oooo.2022.07.006  
  80. Pfister, S. M., Reyes-Mugica, M., Chan, J. K. C., Hasle, H., Lazar, A. J., Rossi, S., . . . Alaggio, R. (2022). A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. Cancer Discovery. 12(2): 331-355. PMID: 34921008 https://doi.org/10.1158/2159-8290.CD-21-1094   
  81. Pinello, K., Baldassarre, V., Steiger, K., Paciello, O., Pires, I., Laufer-Amorim, R., . . . Dagli, M. L. Z. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers. 14(6). PMID: 35326681 https://doi.org/10.3390/cancers14061529          
  82. Reisfeld, B., de Conti, A., El Ghissassi, F., Benbrahim-Tallaa, L., Gwinn, W., Grosse, Y., & Schubauer-Berigan, M. (2022). kc-hits: a tool to aid in the evaluation and classification of chemical carcinogens. Bioinformatics. 38(10): 2961-2962. PMID: 35561175 https://doi.org/10.1093/bioinformatics/btac189         
  83. Richardson, D. B., Rage, E., Demers, P. A., Do, M. T., Fenske, N., Deffner, V., . . . Laurier, D. (2022). Lung Cancer and Radon: Pooled Analysis of Uranium Miners Hired in 1960 or Later. Environmental Health Perspectives. 130(5): 57010. PMID: 35604341 https://doi.org/10.1289/EHP10669         
  84. Samet, J. M., Berrington de Gonzalez, A., Lunn, R. M., & Schubauer-Berigan, M. K. (2022). Commentary: Role and communications of cancer hazard determinations. Carcinogenesis. 43(2): 79-81. PMID: 35016221 https://doi.org/10.1093/carcin/bgac001              
  85. Thierauf, J. C., Farahani, A. A., Indave, B. I., Bard, A. Z., White, V. A., Smith, C. R., . . . Lennerz, J. K. (2022). Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. International Journal of Molecular Sciences. 23(8): 4322. PMID: 35457138 https://doi.org/10.3390/ijms23084322            
  86. White, V. A., Hyrcza, M. D., Lennerz, J. K., Thierauf, J., Lokuhetty, D., Cree, I. A., & Indave, B. I. (2022). Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? Modern Pathology. 35(10): 1484-1493. PMID: 35871081 https://doi.org/10.1038/s41379-022-01100-z               
  87. Yadav, K., Cree, I., Field, A., Vielh, P., & Mehrotra, R. (2022). Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries. JCO Glob Oncol. 8: e2100337. PMID: 35213215 https://doi.org/10.1200/GO.21.00337        
  88. Barupal, D. K., Schubauer-Berigan, M. K., Korenjak, M., Zavadil, J., & Guyton, K. Z. (2021). Prioritizing cancer hazard assessments for IARC Monographs using an integrated approach of database fusion and text mining. Environ Int. 156: 106624. PMID: 33984576  doi: 10.1016/j.envint.2021.106624
  89. Bilal, M., Raza, S. E. A., Azam, A., Graham, S., Ilyas, M., Cree, I. A., . . . Rajpoot, N. M. (2021). Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study. Lancet Digit Health. 3(12): e763-e772. PMID: 34686474  doi: 10.1016/S2589-7500(21)00180-1
  90. Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., . . . Lauby-Secretan, B. (2021). The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 385(20): 1908-1918. PMID: 34758259  doi: 10.1056/NEJMsr2030640
  91. Bruford, E. A., Antonescu, C. R., Carroll, A. J., Chinnaiyan, A., Cree, I. A., Cross, N. C. P., . . . Mitelman, F. (2021). HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. Leukemia. 35(11): 3040-3043. PMID: 34615987  doi: 10.1038/s41375-021-01436-6
  92. Chow, Z. L., Indave, B. I., Lokuhetty, M. D. S., Ochiai, A., Cree, I. A., & White, V. A. (2021). Misleading terminology in pathology: lack of definitions hampers communication. Virchows Arch. 479(2): 425-430. PMID: 33796909  doi: 10.1007/s00428-021-03069-7
  93. Chow, Z. L., Indave, B. I., Lokuhetty, M. D. S., Ochiai, A., Cree, I. A., & White, V. A. (2021). Correction to: Misleading terminology in pathology: Lack of definitions hampers communication. Virchows Arch. 479(2): 439. PMID: 33890126  doi: 10.1007/s00428-021-03101-w
  94. Cree, I. A., Indave Ruiz, B. I., Zavadil, J., McKay, J., Olivier, M., Kozlakidis, Z., . . . participants, I. R. (2021). The International Collaboration for Cancer Classification and Research. Int J Cancer. 148(3): 560-571. PMID: 32818326  doi: 10.1002/ijc.33260
  95. Cree, I. A., Tan, P. H., Travis, W. D., Wesseling, P., Yagi, Y., White, V. A., . . . Scolyer, R. A. (2021). Counting mitoses: SI(ze) matters! Mod Pathol. 34(9): 1651-1657. PMID: 34079071  doi: 10.1038/s41379-021-00825-7
  96. Fraser, K., Hubbs, A., Yanamala, N., Mercer, R. R., Stueckle, T. A., Jensen, J., . . . Erdely, A. (2021). Histopathology of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities in a murine model. Part Fibre Toxicol. 18(1): 47. PMID: 34923995  doi: 10.1186/s12989-021-00440-z
  97. Guyton, K. Z., & Schubauer-Berigan, M. K. (2021). Invited Perspective: Prioritizing Chemical Testing and Evaluation Using Validated in Vitro Assays Relevant to Key Characteristics. Environ Health Perspect. 129(7): 71303. PMID: 34287027  doi: 10.1289/EHP9507
  98. Jimenez, R. C., Casajuana-Martin, N., Garcia-Recio, A., Alcantara, L., Pardo, L., Campillo, M., & Gonzalez, A. (2021). The mutational landscape of human olfactory G protein-coupled receptors. BMC Biol. 19(1): 21. PMID: 33546694  doi: 10.1186/s12915-021-00962-0
  99. Le Curieux, F., Gohlke, J. M., Pronk, A., Andersen, W. C., Chen, G. S., Fang, J. L., . . . grp, I. M. V. (2021). Carcinogenicity of gentian violet, leucogentian violet, malachite green, leucomalachite green, and CI Direct Blue 218. Lancet Oncol. 22(5): 585-586. PMID: 33773614  doi: 10.1016/s1470-2045(21)00178-91
  100. Leske, H., Dalgleish, R., Lazar, A. J., Reifenberger, G., & Cree, I. A. (2021). A common classification framework for histone sequence alterations in tumours: an expert consensus proposal. J Pathol. 254(2): 109-120. PMID: 33779999  doi: 10.1002/path.5666
  101. Leuraud, K., Richardson, D. B., Cardis, E., Daniels, R. D., Gillies, M., Haylock, R., . . . Laurier, D. (2021). Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study. Radiat Environ Biophys. 60(1): 23-39. PMID: 33479781  doi: 10.1007/s00411-020-00890-7
  102. Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., . . . Ellison, D. W. (2021). The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 23(8): 1231-1251. PMID: 34185076  doi: 10.1093/neuonc/noab106
  103. Matos, L. L., Forster, C. H. Q., Marta, G. N., Castro Junior, G., Ridge, J. A., Hirata, D., . . . Kowalski, L. P. (2021). The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer model. Cancer Causes Control. 32(5): 459-471. PMID: 33704627  doi: 10.1007/s10552-021-01411-7
  104. Michels, N., De Backer, F., Dimakopoulou, M., Mane, K., Indave, I., & Huybrechts, I. (2021). Eating disorders and the risk of developing cancer: a systematic review. Eat Weight Disord. 26(4): 1021-1035. PMID: 33025526  doi: 10.1007/s40519-020-01020-4
  105. Mostovenko, E., Dahm, M. M., Schubauer-Berigan, M. K., Eye, T., Erdely, A., Young, T. L., . . . Ottens, A. K. (2021). Serum peptidome: diagnostic window into pathogenic processes following occupational exposure to carbon nanomaterials. Part Fibre Toxicol. 18(1): 39. PMID: 34711247  doi: 10.1186/s12989-021-00431-0
  106. Reynolds, R. R., Davies, M. J., Buffam, F. V., Dolman, P. J., & White, V. A. (2021). Differences in 7th and 8th edition American Joint Committee on Cancer staging for periocular sebaceous carcinoma. Can J Ophthalmol. 56(1): 31-36. PMID: 32822657  doi: 10.1016/j.jcjo.2020.07.017
  107. Richardson, D. B., Rage, E., Demers, P. A., Do, M. T., DeBono, N., Fenske, N., . . . Laurier, D. (2021). Mortality among uranium miners in North America and Europe: the Pooled Uranium Miners Analysis (PUMA). Int J Epidemiol. 50(2): 633-643. PMID: 33232447  doi: 10.1093/ije/dyaa195
  108. Rusyn, I., Arzuaga, X., Cattley, R. C., Corton, J. C., Ferguson, S. S., Godoy, P., . . . Smith, M. T. (2021). Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity. Hepatology. 74(6): 3486-3496. PMID: 34105804  doi: 10.1002/hep.31999
  109. Washington, M. K., Goldberg, R. M., Chang, G. J., Limburg, P., Lam, A. K., Salto-Tellez, M., . . . Board, W. H. O. C. o. T. E. (2021). Diagnosis of digestive system tumours. Int J Cancer. 148(5): 1040-1050. PMID: 32674220  doi: 10.1002/ijc.33210
  110. Arroyave, W. D., Mehta, S. S., Guha, N., Schwingl, P., Taylor, K. W., Glenn, B., . . . Lunn, R. M. (2020). Challenges and recommendations on the conduct of systematic reviews of observational epidemiologic studies in environmental and occupational health. J Expo Sci Environ Epidemiol. 31(1): 21-30. PMID: 32415298 doi: 10.1038/s41370-020-0228-0
  111. Cree, I. A., White, V. A., Indave, B. I., & Lokuhetty, D. (2020). Revising the WHO classification: female genital tract tumours. Histopathology. 76(1): 151-156. PMID: 31846528 doi: 10.1111/his.13977
  112. Elder, D. E., Bastian, B. C., Cree, I. A., Massi, D., & Scolyer, R. A. (2020). The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 144(4): 500-522. PMID: 32057276 doi: 10.5858/arpa.2019-0561-RA
  113. Fraser, K., Kodali, V., Yanamala, N., Birch, M. E., Cena, L., Casuccio, G., . . . Erdely, A. (2020). Physicochemical characterization and genotoxicity of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities. Part Fibre Toxicol. 17(1): 62. PMID: 33287860 doi: 10.1186/s12989-020-00392-w
  114. Ge, C., Peters, S., Olsson, A., Portengen, L., Schüz, J., Almansa, J., . . . Vermeulen, R. (2020). Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure-Response Analysis of 14 Case-Control Studies. Am J Respir Crit Care Med. 202(3): 402-411. PMID: 32330395 doi: 10.1164/rccm.201911-2101OC
  115. Ge, C., Peters, S., Olsson, A., Portengen, L., Schuz, J., Almansa, J., . . . Vermeulen, R. (2020). Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies. Am J Respir Crit Care Med. 202(3): 412-421. PMID: 32330394 doi: 10.1164/rccm.201910-1926OC
  116. Gonzalez-Ericsson, P. I., Stovgaard, E. S., Sua, L. F., Reisenbichler, E., Kos, Z., Carter, J. M., . . . International Immuno-Oncology Biomarker Working, G. (2020). The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. J Pathol. 250(5): 667-684. PMID: 32129476 doi: 10.1002/path.5406
  117. Guseva Canu, I., Gaillen-Guedy, A., Wild, P., Straif, K., & Luce, D. (2020). Lung cancer mortality in the French cohort of titanium dioxide workers: some aetiological insights. Occup Environ Med. 77(11): 795-797. PMID: 32737152 doi: 10.1136/oemed-2020-106522
  118. Hall, A. L., Kromhout, H., Schuz, J., Peters, S., Portengen, L., Vermeulen, R., . . . Olsson, A. (2020). Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix. Epidemiology. 31(1): 145-154. PMID: 31577634 doi: 10.1097/ede.0000000000001120
  119. Huybrechts, I., Zouiouich, S., Loobuyck, A., Vandenbulcke, Z., Vogtmann, E., Pisanu, S., . . . Michels, N. (2020). The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 29(10): 1856-1868. PMID: 32727720 doi: 10.1158/1055-9965.EPI-20-0288
  120. IARC Monographs Vol 126 group (2020). Carcinogenicity of opium consumption. Lancet Oncol. 21(11): 1407-1408. PMID: 33038940 doi: 10.1016/s1470-2045(20)30611-2
  121. Kelly-Reif, K., Sandler, D. P., Shore, D., Schubauer-Berigan, M. K., Troester, M. A., Nylander-French, L., & Richardson, D. B. (2020). Radon and cancer mortality among underground uranium miners in the Pribram region of the Czech Republic. American Journal of Industrial Medicine. 63(10): 859-867. PMID: 33448434 doi: 10.1002/ajim.23167
  122. La Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul, H. B., . . . Zoeller, R. T. (2020). Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 16(1): 45-57. PMID: 31719706 doi: 10.1038/s41574-019-0273-8
  123. Lokuhetty, M. D. S., Wijesinghe, H. D., Damen, J. A. A. G., Lee, T., Whiter, V. A., Cree, I. A., & Indave, B. I. (2020). Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer. Cochrane Database of Systematic Reviews(11): 18. doi: 10.1002/14651858.CD013784
  124. Louis, D. N., Wesseling, P., Aldape, K., Brat, D. J., Capper, D., Cree, I. A., . . . Ellison, D. W. (2020). cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 30(4): 844-856. PMID: 32307792 doi: 10.1111/bpa.12832
  125. Mahmood, H., Shaban, M., Indave, B. I., Santos-Silva, A. R., Rajpoot, N., & Khurram, S. A. (2020). Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: A systematic review. Oral Oncol. 110: 104885. PMID: 32674040 doi: 10.1016/j.oraloncology.2020.104885
  126. Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., . . . Board, W. H. O. C. o. T. E. (2020). The 2019 WHO classification of tumours of the digestive system. Histopathology. 76(2): 182-188. PMID: 31433515 doi: 10.1111/his.13975
  127. Nicholson, A. G., Sauter, J. L., Nowak, A. K., Kindler, H. L., Gill, R. R., Remy-Jardin, M., . . . Galateau-Salle, F. (2020). EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. J Thorac Oncol. 15(1): 29-49. PMID: 31546041 doi: 10.1016/j.jtho.2019.08.2506
  128. Patel, D. M., Jones, R. R., Booth, B. J., Olsson, A. C., Kromhout, H., Straif, K., . . . Ward, M. H. (2020). Parental occupational exposure to pesticides, animals and organic dust and risk of childhood leukemia and central nervous system tumors: Findings from the International Childhood Cancer Cohort Consortium (I4C). Int J Cancer. 146(4): 943-952. PMID: 31054169 doi: 10.1002/ijc.32388
  129. Preti, M., Rotondo, J. C., Holzinger, D., Micheletti, L., Gallio, N., McKay-Chopin, S., . . . Gheit, T. (2020). Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women. Infect Agent Cancer. 15: 20. PMID: 32266002 doi: 10.1186/s13027-020-00286-8
  130. Quezada-Marín, J. I., Lam, A. K., Ochiai, A., Odze, R. D., Washington, K. M., Fukayama, M., . . . Salto-Tellez, M. (2020). Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours. Histopathology. 77(3): 340-350. PMID: 32320495 doi: 10.1111/his.14120
  131. Rage, E., Richardson, D. B., Demers, P. A., Do, M., Fenske, N., Kreuzer, M., . . . Laurier, D. (2020). PUMA – pooled uranium miners analysis: cohort profile. Occup Environ Med. 77(3): 194-200. PMID: 32005674 doi: 10.1136/oemed-2019-105981
  132. Rusyn, I., Belpoggi, F., Camacho, L., Kafferlein, H. U., Cattley, R., Estill, C. F., . . . Grp, I. M. V. (2020). Carcinogenicity of some industrial chemical intermediates and solvents. Lancet Oncology. 21(1): 25-26. PMID: 31787538 doi: 10.1016/S1470-2045(19)30779-X
  133. Rydz, E., Hall, A. L., & Peters, C. E. (2020). Prevalence and Recent Trends in Exposure to Night Shiftwork in Canada. Ann Work Expo Health. 64(3): 270-281. PMID: 32020159 doi: 10.1093/annweh/wxaa001
  134. Salgado, R., Bellizzi, A. M., Rimm, D., Bartlett, J. M. S., Nielsen, T., Holger, M., . . . Cree, I. (2020). How current assay approval policies are leading to unintended imprecision medicine. Lancet Oncol. 21(11): 1399-1401. PMID: 33098760 doi: 10.1016/s1470-2045(20)30592-1
  135. Samet, J. M., Chiu, W. A., Cogliano, V., Jinot, J., Kriebel, D., Lunn, R. M., . . . Wild, C. P. (2020). The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification. J Natl Cancer Inst. 112(1): 30-37. PMID: 31498409 doi: 10.1093/jnci/djz169
  136. Schubauer-Berigan, M. K. (2020). Hazards at 10 000 m: studies of aircrew and their importance in understanding cancer risks from cosmic radiation and circadian disruption. Occup Environ Med. 77(5): 283-284. PMID: 32179634 doi: 10.1136/oemed-2020-106432
  137. Schüz, J., Bukhtiyarov, I., Olsson, A., Moissonnier, M., Ostroumova, E., Feletto, E., . . . Kovalevskiy, E. (2020). Occupational cohort study of current and former workers exposed to chrysotile in mine and processing facilities in Asbest, the Russian Federation: Cohort profile of the Asbest Chrysotile Cohort study. PLoS ONE. 15(7): e0236475. PMID: 32726334 doi: 10.1371/journal.pone.0236475
  138. Smith, M. T., Guyton, K. Z., Kleinstreuer, N., Borrel, A., Cardenas, A., Chiu, W. A., . . . Fielden, M. (2020). The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them. Cancer Epidemiol Biomarkers Prev. 29(10): 1887-1903. PMID: 32152214 doi: 10.1158/1055-9965.Epi-19-1346
  139. Steenland, K., Schubauer-Berigan, M. K., Vermeulen, R., Lunn, R. M., Straif, K., Zahm, S., . . . Pearce, N. (2020). Risk of Bias Assessments and Evidence Syntheses for Observational Epidemiologic Studies of Environmental and Occupational Exposures: Strengths and Limitations. Environ Health Perspect. 128(9): 95002. PMID: 32924579 doi: 10.1289/EHP6980
  140. Tan, P. H., Ellis, I., Allison, K., Brogi, E., Fox, S. B., Lakhani, S., . . . Cree, I. A. (2020). The 2019 World Health Organization classification of tumours of the breast. Histopathology. 77(2): 181-185. PMID: 32056259 doi: 10.1111/his.14091
  141. Uttley, L., Indave, B. I., Hyde, C., White, V., Lokuhetty, D., & Cree, I. (2020). Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both? Int J Cancer. 146(12): 3516-3521. PMID: 32170735 doi: 10.1002/ijc.32975

 

 

 
View Key Publications

 

 

Evidence Synthesis and Classification
About Research Publications Related websites Personnel
Close Reading Mode
UP